The George Institute For Global Health
United Kingdom


Found 4082 results
Filters: Type is Journal Article  [Clear All Filters]
Tsai C, Slater S, Ronto R, Gebel K, Wu J. Removal of sugary drinks from vending machines: an Australian university case study. Australian and New Zealand Journal of Public Health. 2018. doi:10.1111/1753-6405.12827.
De Z, Heerspink H, Jardine M, Perkovic V. Renal trials in diabetes need a platform: time for a global approach?. The Lancet Diabetes and Endocrinology. 2018;6:356 - 358. doi:10.1016/S2213-8587(17)30263-2.
Gálvez V, Li A, Huggins C, et al. Repeated intranasal ketamine for treatment-resistant depression – the way to go? Results from a pilot randomised controlled trial. Journal of Psychopharmacology. 2018;32:397 - 407. doi:10.1177/0269881118760660.
Ramke J, Palagyi A, Petkovic J, Gilbert CE. Reporting of inequalities in blindness in low income and middle income countries: a review of cross sectional surveys. Clin Exp Ophthalmol. 2018;46(1):99-100. doi:10.1111/ceo.13001.
Ohkuma T, Woodward M, Chalmers J. Response to Comment on Ohkuma et al. Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial. Diabetes Care 2017;40:1203-1209. Diabetes Care. 2018;41(3):e39. doi:10.2337/dci17-0060.
Salam A, Atkins E, Rodgers A. Response to 'SPRINT in context: Meta-analysis of trials with baseline normotension and low levels of previous cardiovascular disease'. Journal of Hypertension. 2018;36:1602 - 1603. doi:10.1097/HJH.0000000000001758.
Zhou Z, Yu J, Carcel C, et al. Resuming anticoagulants after anticoagulation-associated intracranial haemorrhage: systematic review and meta-analysis. BMJ Open. 2018;8(5):e019672. doi:10.1136/bmjopen-2017-019672.
Wood AM, Kaptoge S, Butterworth AS, et al. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet. 2018;391(10129):1513-1523. doi:10.1016/S0140-6736(18)30134-X.
Kasner S, Swaminathan B, Lavados P, et al. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. The Lancet Neurology. 2018;17:1053 - 1060. doi:10.1016/S1474-4422(18)30319-3.
Sautenet B, Tong A, Williams G, et al. Scope and Consistency of Outcomes Reported in Randomized Trials Conducted in Adults Receiving Hemodialysis: A Systematic Review. American Journal of Kidney Diseases. 2018;72:62 - 74. doi:10.1053/j.ajkd.2017.11.01